ArticleGlobalization and health2015
Improving regulatory capacity to manage risks associated with trade agreements.
Article in Globalization and health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Public health advocacy strategies to influence policy agendas: lessons from a narrative review of success in trade policy.Globalization and health · 2023Review
- Addressing Malnutrition: The Importance of Political Economy Analysis of Power.International journal of health policy and management · 2021Review
- International investment liberalization, transnational corporations and NCD prevention policy non-decisions: a realist review on the political economy of tobacco, alcohol and ultra-processed food.Globalization and health · 2021Review
- Corporate power and the international trade regime preventing progressive policy action on non-communicable diseases: a realist review.Health policy and planning · 2021Review
- Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.Globalization and health · 2019Article
- International trade and investment: still the foundation for tackling nutrition related non-communicable diseases in the era of Trump?BMJ (Clinical research ed.) · 2019Article
- Economic globalization, nutrition and health: a review of quantitative evidence.Globalization and health · 2019Review
- Trade, investment and public health: compiling the evidence, assembling the arguments.Globalization and health · 2019Article
- The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries.Global social policy · 2018Article
- Achieving universal health coverage in small island states: could importing health services provide a solution?BMJ global health · 2018Article
- Trade is central to achieving the sustainable development goals: a case study of antimicrobial resistance.BMJ (Clinical research ed.) · 2017Article
- Advancing Public Health on the Changing Global Trade and Investment Agenda Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?"International journal of health policy and management · 2017Article
- Commentary: Moving towards policy coherence in trade and health.Journal of public health policy · 2015Article
- Trade and investment liberalization and Asia's noncommunicable disease epidemic: a synthesis of data and existing literature.Globalization and health · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Modern trade negotiations have delivered a plethora of bilateral and regional preferential trade agreements (PTAs), which involve considerable risk to public health, thus placing demands on governments to strengthen administrative regulatory capacities in regard to the negotiation, implementation and on-going management of PTAs. In terms of risk management, the administrative regulatory capacity requisite for appropriate negotiation of PTAs is different to that for the implementation or on-going management of PTAs, but at all stages the capacity needed is expensive, skill-intensive and requires considerable infrastructure, which smaller and poorer states especially struggle to find. It is also a task generally underestimated. If states do not find ways to increase their capacities then PTAs are likely to become much greater drivers of health inequities. Developing countries especially struggle to find this capacity. In this article we set out the importance of administrative regulatory capacity and coordination to manage the risks to public health associated with PTAs, and suggest ways countries can improve their capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.